CorMedix Inc. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
CorMedix Inc. quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2018 to 2022.
  • CorMedix Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 30, 2024 was -$14.2M, a 25.5% decline year-over-year.
  • CorMedix Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$30.3M, a 2.81% decline from 2021.
  • CorMedix Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$29.5M, a 8.32% decline from 2020.
  • CorMedix Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2020 was -$27.2M, a 26.5% decline from 2019.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$30.3M -$827K -2.81% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 -$29.5M -$2.26M -8.32% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$27.2M -$5.7M -26.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 -$21.5M +$5.34M +19.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$26.8M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.